Cargando...

n-Butyl Cyanoacrylate Embolization of Cerebral Arteriovenous Malformations: Results of a Prospective, Randomized, Multi-center Trial

BACKGROUND AND PURPOSE: Liquid n-butyl cyanoacrylate (n-BCA) use for the treatment of arteriovenous malformations (AVM) in the brain has become part of medical practice. However, no study has led to the Food and Drug Administration’s approval of n-BCA for intravascular use. The purpose of this study...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:AJNR Am J Neuroradiol
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Neuroradiology 2002
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7974739/
https://ncbi.nlm.nih.gov/pubmed/12006271
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!